Poliomyelitis Vaccine (Human Diploid Cell)，Live (Beijing Institute Of Biological Products)

脊髓灰质炎减毒活疫苗(人二倍体细胞)（北京生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePoliomyelitis Vaccine (Human Diploid Cell)，Live (Beijing Institute Of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitis, Bulbar

Global Approved IndicationsPoliomyelitis, Bulbar

Approved Indications in ChinaPoliomyelitis, Bulbar

Original Approved Country/TerritoryMainland China

Original Approved Date1987/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesBeijing Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsPoliomyelitis, Bulbar

Inactive IndicationsN/A

Other Information

ATC CodeJ07BF02